Cytokinetics, Incorporated
CYTK
$31.70
-$0.785-2.42%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 51.58% | 75.01% | 87.61% | 86.80% | -6.78% |
| Total Receivables | 141.25% | 1,197.74% | -90.24% | -- | -17.10% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -16.32% | 27.90% | -66.13% | -43.39% | 34.48% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 49.69% | 76.41% | 81.43% | 82.04% | -6.16% |
|
|
|||||
| Total Current Assets | 49.69% | 76.41% | 81.43% | 82.04% | -6.16% |
| Net Property, Plant & Equipment | -1.08% | -4.58% | -9.63% | -9.60% | -9.01% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 62.49% | -3.64% | -5.64% | -7.91% | -3.76% |
| Total Assets | 56.43% | 70.04% | 93.90% | 95.38% | -9.19% |
|
|
|||||
| Total Accounts Payable | 7.52% | -5.29% | -16.06% | -24.61% | -25.29% |
| Total Accrued Expenses | 8.06% | 29.74% | 51.20% | 26.51% | 12.60% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 9.36% | 9.76% | 76.24% | 91.24% | 108.58% |
| Total Finance Division Other Current Liabilities | 867.45% | 486.99% | 31.24% | 298.76% | -24.51% |
| Total Other Current Liabilities | 867.45% | 486.99% | 31.24% | 298.76% | -24.51% |
| Total Current Liabilities | 79.76% | 74.99% | 41.29% | 56.63% | 18.13% |
|
|
|||||
| Total Current Liabilities | 79.76% | 74.99% | 41.29% | 56.63% | 18.13% |
| Long-Term Debt | 26.04% | 26.54% | 25.30% | 5.52% | -0.66% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -4.39% | -6.51% | -6.42% | -6.22% | -6.04% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 26.29% | 25.26% | 24.93% | 76.37% | 27.18% |
| Total Liabilities | 27.09% | 26.96% | 22.94% | 27.15% | 7.63% |
|
|
|||||
| Common Stock & APIC | 40.11% | 48.56% | 64.72% | 65.15% | 24.32% |
| Retained Earnings | -27.37% | -27.91% | -29.18% | -29.54% | -30.90% |
| Treasury Stock & Other | 386.64% | 24,080.00% | 716.36% | 29.90% | 67.23% |
| Total Common Equity | 32.75% | 64.96% | 96.83% | 132.59% | -72.98% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 32.75% | 64.96% | 96.83% | 132.59% | -72.98% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 32.75% | 64.96% | 96.83% | 132.59% | -72.98% |
|
|
|||||